Hereditary breast cancer accounts for 5-10% of all breast cancer diagnoses and is primarily caused by changes (mutations) in two genes called...

BRIGHT provided funding to support a phase II randomized trial to evaluate the safety of two accelerated partial breast irradiation regimens,...